以太幣突破4,300美元創2021年底以來新高 華檢醫療(01931.HK)曾漲27%破頂
據Coindesk數據,以太幣在過去24小時價格上升1.57%至4,314.8美元,為2021年底以來新高,受惠於美元走弱、機構投資者的興趣增加以及交易所持有量穩步減少。比特幣亦升破12萬美元關口,現升3.22%至121,069.03美元。
今早(11日)加密貨幣相關概念股炒上,華檢醫療(01931.HK)高開14.9%後,早段曾漲26.9%高見9.95創歷史高。現報8.64元,升10.2%,成交228.3萬股,涉資2,021.08萬元。歐科雲鏈(01499.HK)現報0.475元,升7.95%。新火科技(01611.HK)現報4.8元,升4.58%。
華夏以太幣(03046.HK)最高見10.44元,現報10.36元,升9.98%。FA南方以太幣(03068.HK)現報20.38元,升9.87%。FA南方比特幣(03066.HK)現報41.12元,升4.05%,成交11.99萬股,涉資487.79萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.